 OncLive | Baselga Recaps Research Into Three Breast Cancer Pathways OncLive You focused on mTOR inhibitors in another of your talks, titled “mTOR Inhibitors: Reversing Resistance to Endocrine Blockade Therapy.” Why have mTOR inhibitors become so important in the treatment of hormone ... Recently, we conducted a phase III study ... |
